Clinical and biochemical evaluation of lozenges containing Lactobacillus reuteri as an adjunct to non-surgical periodontal therapy in chronic periodontitis

Journal of Periodontology

Volumn 86, Issue 6, 2015, Pages 746-754

  Ince, Gizem ^a   Gürsoy, Hare ^a   Ipçi, Şebnem Dirikan ^a   Cakar, Gokser ^a   Emekli Alturfan, Ebru ^b   Yilmaz, Selçuk ^a  

^a YEDITEPE UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

Author keywords

Chronic periodontitis; Dental scaling; Gingival crevicular fluid; Matrix metalloproteinase 8; Probiotics; Tissue inhibitor of metalloproteinase 1.

Indexed keywords

MMP8 PROTEIN, HUMAN; NEUTROPHIL COLLAGENASE; PLACEBO; PROBIOTIC AGENT; TABLET; TIMP1 PROTEIN, HUMAN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; CHRONIC PERIODONTITIS; COMPARATIVE STUDY; CONTROLLED STUDY; DENTAL DEBRIDEMENT; DENTAL SCALING; DOUBLE BLIND PROCEDURE; ENZYMOLOGY; FEMALE; FOLLOW UP; GINGIVITIS; HUMAN; LACTOBACILLUS REUTERI; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; PLAQUE INDEX; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; ROOT PLANING; TABLET;

ADULT; CHRONIC PERIODONTITIS; COMBINED MODALITY THERAPY; DENTAL PLAQUE INDEX; DENTAL SCALING; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GINGIVAL CREVICULAR FLUID; HUMANS; LACTOBACILLUS REUTERI; MALE; MATRIX METALLOPROTEINASE 8; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL DEBRIDEMENT; PERIODONTAL INDEX; PERIODONTAL POCKET; PLACEBOS; PROBIOTICS; ROOT PLANING; TABLETS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 84930390193     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2015.140612     Document Type: Article

References (49)

1. Food and Agriculture Organization/World Health Organization. Report of joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Cordoba, Argentina; 2001:1-30.
2. Teughels W, Loozen G, Quirynen M. Do probiotics offer opportunities to manipulate the periodontal oral microbiota? J Clin Periodontol 2011;38(Suppl. 11):159-177.
3. Williams NT. Probiotics. Am J Health Syst Pharm 2010;67:449-458.
4. Saad N, Delattre C, Urdaci M, Schmitter JM, Bressollier P. An overview of the last advances in probiotic and prebiotic field. LWT Food Sci Technol 2012;50:1-16.
5. Saglam M, Kantarci A, Dündar N, Hakki SS. Clinical and biochemical effects of diode laser as an adjunct to nonsurgical treatment of chronic periodontitis: A randomized, controlled clinical trial. Lasers Med Sci 2014;29:37-46.
6. Reynolds JJ. Collagenases and tissue inhibitors of metalloproteinases: A functional balance in tissue degradation. Oral Dis 1996;2:70-76.
7. Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS. Advances in the pathogenesis of periodontitis: Summary of developments, clinical implications and future directions. Periodontol 2000 1997;14:216-248.
8. Tüter G, Serdar M, Kurtiş B, et al. Effects of scaling and root planing and subantimicrobial dose doxycycline on gingival crevicular fluid levels of matrix metalloproteinase-8, -13 and serum levels of HsCRP in patients with chronic periodontitis. J Periodontol 2010;81:1132-1139.
9. Mancini S, Romanelli R, Laschinger CA, Overall CM, Sodek J, McCulloch CA. Assessment of a novel screening test for neutrophil collagenase activity in the diagnosis of periodontal diseases. J Periodontol 1999;70:1292-1302.
10. Chen HY, Cox SW, Eley BM, Mäntylä P, Rönkä H, Sorsa T. Matrix metalloproteinase-8 levels and elastase activities in gingival crevicular fluid from chronic adult periodontitis patients. J Clin Periodontol 2000;27:366-369.
11. Kinane DF, Darby IB, Said S, et al. Changes in gingival crevicular fluid matrix metalloproteinase-8 levels during periodontal treatment and maintenance. J Periodontal Res 2003;38:400-404.
12. Sorsa T, Tjäderhane L, Salo T. Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis 2004;10:311-318.
13. Passoja A, Ylipalosaari M, Tervonen T, Raunio T, Knuuttila M. Matrix metalloproteinase-8 concentration in shallow crevices associated with the extent of periodontal disease. J Clin Periodontol 2008;35:1027-1031.
14. Han B, Emingil G, Özdemir G, et al. Azithromycin as an adjunctive treatment of generalized severe chronic periodontitis: Clinical, microbiologic, and biochemical parameters. J Periodontol 2012;83:1480-1491.
15. Krasse P, Carlsson B, Dahl C, Paulsson A, Nilsson A, Sinkiewicz G. Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri. Swed Dent J 2006;30:55-60.
16. Riccia DN, Bizzini F, Perilli MG, et al. Anti-inflammatory effects of Lactobacillus brevis (CD2) on periodontal disease. Oral Dis 2007;13:376-385.
17. Twetman S, Derawi B, Keller M, Ekstrand K, Yucel-Lindberg T, Stecksen-Blicks C. Short-term effect of chewing gums containing probiotic Lactobacillus reuteri on the levels of inflammatory mediators in gingival crevicular fluid. Acta Odontol Scand 2009;67:19-24.
18. Teughels W, Durukan A, Ozcelik O, Pauwels M, Quirynen M, Haytac MC. Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: A randomized placebo-controlled study. J Clin Periodontol 2013;40:1025-1035.
19. Mayanagi G, Kimura M, Nakaya S, et al. Probiotic effects of orally administered Lactobacillus salivarius WB21-containing tablets on periodontopathic bacteria: A double-blinded, placebo-controlled, randomized clinical trial. J Clin Periodontol 2009;36:506-513.
20. Hallström H, Lindgren S, Yucel-Lindberg T, Dahlén G, Renvert S, Twetman S. Effect of probiotic lozenges on inflammatory reactions and oral biofilm during experimental gingivitis. Acta Odontol Scand 2013;71:828-833.
21. Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. Ann Int Med 2010;152.
22. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
23. Urbaniak GC, Plous S. Research Randomizer. Available at: http://www.randomizer.org. Accessed September 2012.
24. Löe H, Silness J. Periodontal disease in pregnancy. I. Prevelance and severity. Acta Odontol Scand 1963;21:533-551.
25. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal conditioning. Acta Odontol Scand 1964;22:121-135.
26. Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J 1975;25:229-235.
27. Griffiths GS, Curtis MA, Wilton JM. Selection of a filter paper with optimum properties for the collection of gingival crevicular fluid. J Periodontal Res 1988;23:33-38.
28. Vivekananda MR, Vandana KL, Bhat KG. Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of periodontal disease: A preliminary randomized clinical trial. J Oral Microbiol 2010;2:5344-5352.
29. Adriaens PA, Adriaens LM. Effects of nonsurgical periodontal therapy on hard and soft tissues. Periodontol 2000 2004;36:121-145.
30. Harper DS, Robinson PJ. Correlation of histometric, microbial, and clinical indicators of periodontal disease status before and after root planing. J Clin Periodontol 1987;14:190-196.
31. Loesche WJ, Giordano J, Soehren S, et al. Nonsurgical treatment of patients with periodontal disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;81:533-543.
32. Vicario M, Santos A, Violant D, Nart J, Giner L. Clinical changes in periodontal subjects with the probiotic Lactobacillus reuteri Prodentis: A preliminary randomized clinical trial. Acta Odontol Scand 2013;71:813-819.
33. Stamatova I, Meurman JH. Probiotics and periodontal disease. Periodontol 2000 2009;51:141-151.
34. Shimauchi H, Mayanagi G, Nakaya S, et al. Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21: A randomized, double-blind, placebo-controlled study. J Clin Periodontol 2008;35:897-905.
35. Staab B, Eick S, Knöfler G, Jentsch H. The influence of a probiotic milk drink on the development of gingivitis: A pilot study. J Clin Periodontol 2009;36:850-856.
36. Slawik S, Staufenbiel I, Schilke R, et al. Probiotics affect the clinical inflammatory parameters of experimental gingivitis in humans. Eur J Clin Nutr 2011;65:857-863.
37. Iniesta M, Herrera D, Montero E, et al. Probiotic effects of orally administered Lactobacillus reuteri-containing tablets on the subgingival and salivary microbiota in patients with gingivitis. A randomized clinical trial. J Clin Periodontol 2012;39:736-744.
38. Teughels W, Van Essche M, Sliepen I, Quirynen M. Probiotics and oral healthcare. Periodontol 2000 2008;48:111-147.
39. Kubota T, Matsuki Y, Nomura T, Hara K. In situ hybridization study on tissue inhibitors of metalloproteinases (TIMPs) mRNA-expressing cells in human inflamed gingival tissue. JPeriodontalRes1997;32:467-472.
40. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res 2003;92:827-839.
41. Michail S, Abernathy F. Lactobacillus plantarum reduces the in vitro secretory response of intestinal epithelial cells to enteropathogenic Escherichia coli infection. J Pediatr Gastroenterol Nutr 2002;35:350-355.
42. Zhang G, Chen R, Rudney JD. Streptococcus cristatus attenuates Fusobacterium nucleatum-induced interleukin-8 expression in oral epithelial cells. J Periodontal Res 2008;43:408-416.
43. Reid G, Jass J, Sebulsky MT, McCormick JK. Potential uses of probiotics in clinical practice. Clin Microbiol Rev 2003;16:658-672.
44. Kligler B, Cohrssen A. Probiotics. Am Fam Physician 2008;78:1073-1078.
45. Tüter G, Kurtiş B, Serdar M. Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1. J Periodontol 2002;73:487-493.
46. Alpagot T, Bell C, Lundergan W, Chambers DW, Rudin R. Longitudinal evaluation of GCF MMP-3 and TIMP-1 levels as prognostic factors for progression of periodontitis. J Clin Periodontol 2001;28:353-359.
47. Haerian A, Adonogianaki E, Mooney J, Manos A, Kinane DF. Effects of treatment on gingival crevicular collagenase, stromelysin and tissue inhibitor of metalloproteinases and their ability to predict response to treatment. J Clin Periodontol 1996;23:83-91.
48. Gursoy UK, Könönen E, Pradhan-Palikhe P, et al. Salivary MMP-8, TIMP-1, and ICTP as markers of advanced periodontitis. J Clin Periodontol 2010;37:487-493.
49. Uitto VJ, Overall CM, McCulloch C. Proteolytic host cell enzymes in gingival crevice fluid. Periodontol 2000 2003;31:77-104.